In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 9, 2004, Pages 3279-3283

  Yekutiel, Aya ^a   Shalit, Itamar ^a,b   Shadkchan, Yona ^a   Osherov, Nir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; SULFAMETHOXAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; CELL WALL; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENTIATION; FUNGAL CELL; FUNGUS HYPHAE; FUNGUS ISOLATION; IN VITRO STUDY; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; DRUG COMBINATIONS; DRUG SYNERGISM; FLUORESCENT DYES; HUMANS; HYPHAE; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, FLUORESCENCE; PEPTIDES; PEPTIDES, CYCLIC; SULFAMETHOXAZOLE; TETRAZOLIUM SALTS;

EID: 4344693412     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.9.3279-3283.2004     Document Type: Article

References (16)

1. Afeltra, J., J. F. Meis, J. W. Mouton, and P. E. Verweij. 2001. Prevention of invasive aspergillosis in AIDS by sulfamethoxazole. AIDS 15:1067-1068.
2. Afeltra, J., J. F. Meis, R. G. Vitale, J. W. Mouton, and P. E. Verweij. 2002. In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species. Antimicrob. Agents Chemother. 46:2029-2031.
3. Arikan, S., M. Lozano-Chiu, V. Paetznick, and J. H. Rex. 2002. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob. Agents Chemother. 46:245-247.
4. Bayley, A. M., and I. G. Macreadie. 2002. Folic acid antagonism of sulfa drug treatments. Trends Parasitol. 18:49-50.
5. Brown, J. S., A. Aufauvre-Brown, J. Brown, J. M. Jennings, H. J. Arst, and D. W. Holden. 2000. Signature-tagged and directed mutageneses identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity. Mol. Microbiol. 36:1371-1380.
6. Castelli, L. A., N. P. Nguyen, and I. G. Macreadie. 2001. Sulfa drug screening in yeast: fifteen sulfa drugs compete with p-aminobenzoate in Saccharomyces cerevisiae. FEMS Microbiol. Lett. 199:181-184.
7. Chiou, C. C., N. Mavrogiorgos, E. Tillem, R. Hector, and T. J. Walsh. 2001. Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus. Antimicrob. Agents Chemother. 45:3310-3321.
8. Georgopapadakou, N. H. 1998. Antifungals: mechanism of action and resistance, established and novel drugs. Curr. Opin. Microbiol. 1:547-557.
9. Hong, Y. L., P. A. Hossler, D. H. Calhoun, and S. R. Meshnick. 1995. Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. Antimicrob. Agents Chemother. 39:1756-1763.
10. Latge, J. P. 1999. Aspergillus fumigatus and aspergillosis. Clin. Microbiol. Rev. 12:310-350.
11. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, J. P. Donnelly, and P. E. Verweij. 2001. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:3402-3408.
12. Nakajima, R., A. Kitamura, K. Someya, M. Tanaka, and K. Sato. 1995. In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi. Antimicrob. Agents Chemother. 39:1517-1521.
13. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standards. NCCLS document M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Perea, S., and T. F. Patterson. 2002. Invasive Aspergillus infections in hematologic malignancy patients. Semin. Respir. Infect. 17:99-105.
15. Perea, S., G. Gonzalez, A. W. Fothergill, W. R. Kirkpatrick, M. G. Rinaldi, and T. F. Patterson. 2002. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob. Agents Chemother. 46:3039-3041.
16. Shalit, I., Y. Shadkchan, Z. Samra, and N. Osherov. 2003. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob. Agents Chemother. 47:1416-1418.